#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leukodystrophy Rhabdoid tumour Multifocal motor neuropathy Lennox-Gastaut syndrome Wiskott-Aldrich syndrome PIK3CA related overgrowth spectrum Acute myeloid leukaemia refractory Haemophilia A without inhibitors Netherton's syndrome Hepatoblastoma Sickle cell disease Pouchitis Neuroendocrine tumour of the lung Andersen-Tawil syndrome Small cell lung cancer limited stage More trials…

    Learn about Rare Diseases

    Activated PI3 kinase delta syndrome – Treatment Mucopolysaccharidosis III – Trials in Disease Mantle cell lymphoma – Trials in Disease Hereditary angioedema – Treatment Pituitary-dependent Cushing’s syndrome Waldenstrom’s macroglobulinaemia refractory – Basic Information Amyotrophic lateral sclerosis Undifferentiated sarcoma – Life with Disease Choroid melanoma – Life with Disease Glycogen storage disease type II – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Apocynin Human Coagulation Factor Ix Abt-494 Morphine Hydrochloride Brepocitinib Tosilate Pivmecillinam Hydrochloride M-(18F)-Fluorobenzylguanidine Emiplacel Cilastatin Thiamazole Quercetin GSK4524101A Dl-Alpha-Tocopherol Antithymocyte Immunoglobulin Glucose Monohydrate Florquinitau (18F) Sotatercept Meglumine Gadoterate Bi 1015550 Garetosmab More therapies…

    Learn about Your Condition

    Vulvovaginal candidiasis Lung adenocarcinoma Ataxia telangiectasia Obliterative bronchiolitis Breast cancer in situ Muscle strain Chondroplasty High-grade B-cell lymphoma Trigeminal neuralgia Papulopustular rosacea Dyspnoea Nasal sinus cancer Medulloblastoma recurrent Cutibacterium acnes infection Monkeypox More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Comparing intermediate and standard doses of enoxaparin to prevent blood clots in patients with severe trauma

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Thrombosis prophylaxis
    Investigated Drugs:
    • Enoxaparin Sodium
    • Sodium Chloride
    France

  • Study of Intravenous Immunoglobulin Added to Standard Treatment for COVID-19 in Patients with Severely Weakened Immune System Due to B-cell Problems

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Remdesivir
    • Nirmatrelvir
    • Human Normal Immunoglobulin
    Sweden

  • Testing the Immune Response to Trivalent Inactivated Influenza Vaccine in People with Obesity and Type 2 Diabetes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    • Obesity
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
    • Influenza A/Victoria/4897/2022 Ivr-238 (H1N1), Inactivated
    • Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26)
    Sweden

  • Testing Psilocybin with Therapy for Treatment of Gambling Disorder in Adults with Problem Gambling

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Hypromellose
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    France

  • Testing Bacteriophage Cocktail Safety and Effectiveness in Patients with Complicated Infected Wounds Compared to Placebo

    Not yet recruiting

    4 1 1
    Investigated Drugs:
    • Sodium Chloride
    Czechia

  • Study of paracetamol effects on emotions and thinking in healthy adults aged 18 to 30 years

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Paracetamol
    Norway
Previous Page
1 … 745 746 747 748 749 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!